223
References
Akdag I, Ozkirimli E (2013) The uptake mechanism of the cell-penetrating pVEC peptide. J Chem
2013:1–9. https://doi.org/10.1155/2013/851915
Alaybeyoglu B, SariyarAkbulut B, Ozkirimli E (2018) pVEC hydrophobic N-terminus is critical
for antibacterial activity. J Pept Sci 24(6):e3083. https://doi.org/10.1002/psc.3083
Allcock S, Young EH, Holmes M, Gurdasani D, Dougan G, Sandhu MS et al (2017) Antimicrobial
resistance in human populations: challenges and opportunities. Glob Health Epidemiol Genom
2:e4. https://doi.org/10.1017/gheg.2017.4
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ et al (2016)
Implementing an Antibiotic Stewardship Program: guidelines by the Infectious Diseases
Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis
62(10):e51–e77. https://doi.org/10.1093/cid/ciw118
Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A (2017) Antimicrobial resistance
in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med
43(10):1464–1475. https://doi.org/10.1007/s00134-017-4878-x
Benincasa M, Pacor S, Gennaro R, Scocchi M (2009) Rapid and reliable detection of antimicrobial
peptide penetration into gram-negative bacteria based on fluorescence quenching. Antimicrob
Agents Chemother 53(8):3501–3504. https://doi.org/10.1128/AAC.01620-08
Bennadi D (2013) Self-medication: a current challenge. J Basic Clin Pharm 5(1):19–23. https://
doi.org/10.4103/0976-0105.128253
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ (2015) Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13(1):42–51. https://doi.org/10.1038/nrmicro3380
Boparai JK, Sharma PK (2019) Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein Pept Lett 27:4–16. https://doi.org/10.217
4/0929866526666190822165812
Borysowski J, Gorski A (2008) Is phage therapy acceptable in the immunocompromised host? Int
J Infect Dis 12(5):466–471. https://doi.org/10.1016/j.ijid.2008.01.006
Capitanio D, Moriggi M, Torretta E, Barbacini P, De Palma S, Vigano A et al (2020) Comparative
proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles:
changes contributing to preserve muscle function in Becker muscular dystrophy patients. J
Cachexia Sarcopenia Muscle 11:547–563. https://doi.org/10.1002/jcsm.12527
Chan JH, Lim S, Wong WS (2006) Antisense oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol 33(5–6):533–540. https://doi.
org/10.1111/j.1440-1681.2006.04403.x
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev
Genet 13(4):260–270. https://doi.org/10.1038/nrg3182
Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C et al (1994) Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocorisapterus. Biochem
J 300(Pt 2):567–575. https://doi.org/10.1042/bj3000567
de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T et al (2016) Strategies to
enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious
Diseases. Infection 44(3):395–439. https://doi.org/10.1007/s15010-016-0885-z
Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP et al (2007) Infectious
Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect
Dis 44(2):159–177. https://doi.org/10.1086/510393
Dik JW, Poelman R, Friedrich AW, Panday PN, Lo-Ten-Foe JR, van Assen S et al (2016) An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future
Microbiol 11(1):93–102. https://doi.org/10.2217/fmb.15.99
Domingo-Calap P, Georgel P, Bahram S (2016) Back to the future: bacteriophages as promising
therapeutic tools. HLA 87(3):133–140. https://doi.org/10.1111/tan.12742
Duckworth DH (1976) Who discovered bacteriophage? Bacteriol Rev 40(4):793–802
9 Drug Discovery for Targeting Drug Resistant Bacteria
References
Akdag I, Ozkirimli E (2013) The uptake mechanism of the cell-penetrating pVEC peptide. J Chem
2013:1–9. https://doi.org/10.1155/2013/851915
Alaybeyoglu B, SariyarAkbulut B, Ozkirimli E (2018) pVEC hydrophobic N-terminus is critical
for antibacterial activity. J Pept Sci 24(6):e3083. https://doi.org/10.1002/psc.3083
Allcock S, Young EH, Holmes M, Gurdasani D, Dougan G, Sandhu MS et al (2017) Antimicrobial
resistance in human populations: challenges and opportunities. Glob Health Epidemiol Genom
2:e4. https://doi.org/10.1017/gheg.2017.4
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ et al (2016)
Implementing an Antibiotic Stewardship Program: guidelines by the Infectious Diseases
Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis
62(10):e51–e77. https://doi.org/10.1093/cid/ciw118
Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A (2017) Antimicrobial resistance
in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med
43(10):1464–1475. https://doi.org/10.1007/s00134-017-4878-x
Benincasa M, Pacor S, Gennaro R, Scocchi M (2009) Rapid and reliable detection of antimicrobial
peptide penetration into gram-negative bacteria based on fluorescence quenching. Antimicrob
Agents Chemother 53(8):3501–3504. https://doi.org/10.1128/AAC.01620-08
Bennadi D (2013) Self-medication: a current challenge. J Basic Clin Pharm 5(1):19–23. https://
doi.org/10.4103/0976-0105.128253
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ (2015) Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13(1):42–51. https://doi.org/10.1038/nrmicro3380
Boparai JK, Sharma PK (2019) Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein Pept Lett 27:4–16. https://doi.org/10.217
4/0929866526666190822165812
Borysowski J, Gorski A (2008) Is phage therapy acceptable in the immunocompromised host? Int
J Infect Dis 12(5):466–471. https://doi.org/10.1016/j.ijid.2008.01.006
Capitanio D, Moriggi M, Torretta E, Barbacini P, De Palma S, Vigano A et al (2020) Comparative
proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles:
changes contributing to preserve muscle function in Becker muscular dystrophy patients. J
Cachexia Sarcopenia Muscle 11:547–563. https://doi.org/10.1002/jcsm.12527
Chan JH, Lim S, Wong WS (2006) Antisense oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol 33(5–6):533–540. https://doi.
org/10.1111/j.1440-1681.2006.04403.x
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev
Genet 13(4):260–270. https://doi.org/10.1038/nrg3182
Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C et al (1994) Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocorisapterus. Biochem
J 300(Pt 2):567–575. https://doi.org/10.1042/bj3000567
de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T et al (2016) Strategies to
enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious
Diseases. Infection 44(3):395–439. https://doi.org/10.1007/s15010-016-0885-z
Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP et al (2007) Infectious
Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect
Dis 44(2):159–177. https://doi.org/10.1086/510393
Dik JW, Poelman R, Friedrich AW, Panday PN, Lo-Ten-Foe JR, van Assen S et al (2016) An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future
Microbiol 11(1):93–102. https://doi.org/10.2217/fmb.15.99
Domingo-Calap P, Georgel P, Bahram S (2016) Back to the future: bacteriophages as promising
therapeutic tools. HLA 87(3):133–140. https://doi.org/10.1111/tan.12742
Duckworth DH (1976) Who discovered bacteriophage? Bacteriol Rev 40(4):793–802
9 Drug Discovery for Targeting Drug Resistant Bacteria